Close

More on ITOS

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (5/9/24)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

iTeos Therapeutics (NQ:ITOS)
Delayed: 10.56 +0.23 (2.23%)
Prev. Close $10.33  
Open$10.27 
52 Wk High$ 
52 Wk Low$ 
Day High$10.61 
Day Low$10.01 
P/E N/A  
EPS$ 
Volume943,394 

Friends, Peers and Foes (?): VYX, SPGI, NCR, RCUS, NATL (more...)

Apr 7, 2024 04:30 PM iTeos Presents EOS-984 Preclinical Data Demonstrating Restoration of T Cell Activity from Adenosine Suppression at the American Association for Cancer Research Annual Meeting 2024
Mar 12, 2024 07:11 AM iTeos Therapeutics (ITOS) PT Lowered to $27 at JPMorgan
Mar 8, 2024 08:02 PM Form 4 iTeos Therapeutics, Inc. For: Mar 07 Filed by: Gall Matthew
Mar 8, 2024 08:01 PM Form 4 iTeos Therapeutics, Inc. For: Mar 07 Filed by: Call Matthew
Mar 8, 2024 07:59 PM Form 4 iTeos Therapeutics, Inc. For: Mar 07 Filed by: McGrath Yvonne
Mar 8, 2024 07:58 PM Form 4 iTeos Therapeutics, Inc. For: Mar 07 Filed by: Detheux Michel
Mar 7, 2024 08:02 PM Form 4 iTeos Therapeutics, Inc. For: Mar 07 Filed by: DeSimone Jill
Mar 7, 2024 08:01 PM Form 3 iTeos Therapeutics, Inc. For: Mar 07 Filed by: DeSimone Jill
Mar 6, 2024 01:13 PM iTeos Therapeutics (ITOS) PT Lowered to $18 at Wedbush
Mar 6, 2024 07:39 AM iTeos Therapeutics, Inc. (ITOS) Misses Q4 EPS by 2c
View All Articles

Entities mentioned with ITOS

View All Entities